Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1986-12-29
pubmed:databankReference
pubmed:abstractText
Polyomavirus small t antigen was purified from genetically engineered Escherichia coli and used as the immunogen for the production of polyclonal and monoclonal antibodies. A new series of plasmids for increased expression of polyomavirus T antigens or a T antigen-beta-galactosidase fusion protein was constructed by replacing sequences coding for the ribosome-binding site of previously published plasmids with a chemically synthesized sequence that has a higher degree of complementarity to the 3' end of the 16S rRNA. Cells expressing the fusion protein from the plasmid with the synthetic sequence contained 5- to 10-fold more fusion protein after a 3-h induction than did control cells. Pulse-labeling of cells bearing the new plasmids revealed that the T antigens were synthesized at high levels after induction: 10% of total synthesis for small t; 15% for Py-1387T middle T, a truncated mutant of middle T; and probably 1 to 5% for middle T. Small t and Py-1387T middle T, but not wild-type middle T, were seen as minor bands in total cell protein analyzed on sodium dodecyl sulfate-polyacrylamide gels stained with Coomassie blue. A simple, rapid procedure for purification of bacterial small t from the pellet of sonicated bacteria yielded 1 to 2 mg of small t per liter of bacterial culture at 80 to 90% homogeneity. High-titer polyclonal rabbit antisera raised against purified small t recognized all three T antigens and were suitable for immunoaffinity purification of middle T. Mouse monoclonal antibodies raised against bacterial small t were of four classes, immunoprecipitating either all three polyomavirus T antigens, small t and middle T only, primarily small t, or middle T and large T in preference to small t. One of the latter monoclonal antibodies also immunoprecipitated large T but not small t of simian virus 40, suggesting that the site recognized by this antibody may be functionally important. None of the monoclonal antibodies yielded an immunoprecipitate active in phosphorylating middle T in vitro.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/3023660-149110, http://linkedlifedata.com/resource/pubmed/commentcorrection/3023660-168683, http://linkedlifedata.com/resource/pubmed/commentcorrection/3023660-186787, http://linkedlifedata.com/resource/pubmed/commentcorrection/3023660-203944, http://linkedlifedata.com/resource/pubmed/commentcorrection/3023660-229972, http://linkedlifedata.com/resource/pubmed/commentcorrection/3023660-229973, http://linkedlifedata.com/resource/pubmed/commentcorrection/3023660-229974, http://linkedlifedata.com/resource/pubmed/commentcorrection/3023660-2424008, http://linkedlifedata.com/resource/pubmed/commentcorrection/3023660-2981329, http://linkedlifedata.com/resource/pubmed/commentcorrection/3023660-2987699, http://linkedlifedata.com/resource/pubmed/commentcorrection/3023660-2987799, http://linkedlifedata.com/resource/pubmed/commentcorrection/3023660-3012562, http://linkedlifedata.com/resource/pubmed/commentcorrection/3023660-3016331, http://linkedlifedata.com/resource/pubmed/commentcorrection/3023660-3088563, http://linkedlifedata.com/resource/pubmed/commentcorrection/3023660-4887520, http://linkedlifedata.com/resource/pubmed/commentcorrection/3023660-5432063, http://linkedlifedata.com/resource/pubmed/commentcorrection/3023660-558524, http://linkedlifedata.com/resource/pubmed/commentcorrection/3023660-6091900, http://linkedlifedata.com/resource/pubmed/commentcorrection/3023660-6095063, http://linkedlifedata.com/resource/pubmed/commentcorrection/3023660-6098822, http://linkedlifedata.com/resource/pubmed/commentcorrection/3023660-6158095, http://linkedlifedata.com/resource/pubmed/commentcorrection/3023660-6169844, http://linkedlifedata.com/resource/pubmed/commentcorrection/3023660-6175960, http://linkedlifedata.com/resource/pubmed/commentcorrection/3023660-6179082, http://linkedlifedata.com/resource/pubmed/commentcorrection/3023660-6204863, http://linkedlifedata.com/resource/pubmed/commentcorrection/3023660-6254066, http://linkedlifedata.com/resource/pubmed/commentcorrection/3023660-6260373, http://linkedlifedata.com/resource/pubmed/commentcorrection/3023660-6262529, http://linkedlifedata.com/resource/pubmed/commentcorrection/3023660-6287461, http://linkedlifedata.com/resource/pubmed/commentcorrection/3023660-6290466, http://linkedlifedata.com/resource/pubmed/commentcorrection/3023660-6294132, http://linkedlifedata.com/resource/pubmed/commentcorrection/3023660-6294529, http://linkedlifedata.com/resource/pubmed/commentcorrection/3023660-6304524, http://linkedlifedata.com/resource/pubmed/commentcorrection/3023660-6308618, http://linkedlifedata.com/resource/pubmed/commentcorrection/3023660-6312293, http://linkedlifedata.com/resource/pubmed/commentcorrection/3023660-6313968, http://linkedlifedata.com/resource/pubmed/commentcorrection/3023660-6325177, http://linkedlifedata.com/resource/pubmed/commentcorrection/3023660-6325896, http://linkedlifedata.com/resource/pubmed/commentcorrection/3023660-6327264, http://linkedlifedata.com/resource/pubmed/commentcorrection/3023660-6984190, http://linkedlifedata.com/resource/pubmed/commentcorrection/3023660-803646, http://linkedlifedata.com/resource/pubmed/commentcorrection/3023660-942051
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0022-538X
pubmed:author
pubmed:issnType
Print
pubmed:volume
60
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1075-84
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed:year
1986
pubmed:articleTitle
Polyomavirus small t antigen: overproduction in bacteria, purification, and utilization for monoclonal and polyclonal antibody production.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't